UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

Not Applicable

Completed

Conditions: Myeloproliferative Neoplasm
Untreated Adult Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia-2
Myelodysplastic Syndrome

Interventions: Drug: Cytarabine
Drug: Decitabine
Other: Laboratory Biomarker Analysis

First Posted Date: 2014-04-23

Last Posted Date: 2018-04-13

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT02121418

Locations: 🇺🇸
EvergreenHealth Medical Center, Kirkland, Washington, United States
🇺🇸
Olympic Medical Center, Port Angeles, Washington, United States
🇺🇸
Skagit Valley Hospital, Mount Vernon, Washington, United States

and more 6 locations

Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF

Completed

Conditions: Cystic Fibrosis Pulmonary Exacerbation
Lung Infection
Cystic Fibrosis

First Posted Date: 2014-04-10

Last Posted Date: 2016-10-26

Lead Sponsor: University of Washington

Target Recruit Count: 220

Registration Number: NCT02109822

Locations: 🇺🇸
CFF Care Center & Pediatric Program Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

and more 9 locations

Study of Exercise on Impact of Cognitive Functioning in Multiple Sclerosis Patients

Not Applicable

Conditions: Multiple Sclerosis

Interventions: Other: Aerobic exercise
Other: Stretching and toning exercise

First Posted Date: 2014-04-07

Last Posted Date: 2020-05-05

Lead Sponsor: University of Washington

Target Recruit Count: 117

Registration Number: NCT02106052

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Beginning Relationships in a Native Community

Not Applicable

Completed

Conditions: Parent-child Interaction

Interventions: Behavioral: Wait-List group
Behavioral: Immediate Group

First Posted Date: 2014-03-19

Last Posted Date: 2021-10-08

Lead Sponsor: University of Washington

Target Recruit Count: 34

Registration Number: NCT02091804

Locations: 🇺🇸
Nimiipuu Health Community Clinic, Lapwai, Idaho, United States

Comparing Engage to PST for Late Life Depression

Not Applicable

Completed

Conditions: Major Depression

Interventions: Behavioral: Engage
Behavioral: Problem Solving Therapy

First Posted Date: 2014-03-13

Last Posted Date: 2021-06-29

Lead Sponsor: University of Washington

Target Recruit Count: 262

Registration Number: NCT02086201

Locations: 🇺🇸
Weill Medical College of Cornell University, White Plains, New York, United States
🇺🇸
University of Washington Department of Psychiatry and Behavioral Sciences, Seattle, Washington, United States

Pain and Symptom Management in Rural Communities

Not Applicable

Completed

Conditions: Chronic Pain
Palliative Care

Interventions: Behavioral: telehealth enhanced pain management

First Posted Date: 2014-02-25

Last Posted Date: 2017-08-11

Lead Sponsor: University of Washington

Target Recruit Count: 259

Registration Number: NCT02070874

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Effects of a Kappa Agonist on Hot Flashes in Menopausal Women

Phase 1

Completed

Conditions: Treatment of Menopausal Hot Flashes

Interventions: Other: Placebo
Drug: Standard Dose Kappa Agonist
Drug: Half Dose Kappa Agonist

First Posted Date: 2014-02-25

Last Posted Date: 2015-07-01

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT02070718

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus
Immune Reconstitution Inflammatory Syndrome

Interventions: Other: Urgent ART
Other: Early ART

First Posted Date: 2014-02-17

Last Posted Date: 2018-05-14

Lead Sponsor: University of Washington

Target Recruit Count: 183

Registration Number: NCT02063880

Locations: 🇰🇪
Mbagathi District Hospital, Nairobi, Kenya
🇰🇪
Kisumu District Hospital, Kisumu, Kenya
🇰🇪
JOOTRH, Kisumu, Kenya

and more 1 locations

RA-2 13-cis Retinoic Acid (Isotretinoin)

Phase 2

Completed

Conditions: Male Infertility
Klinefelter's Syndrome
Y-chromosome Microdeletions

Interventions: Drug: 13-cis retinoic acid
Drug: Calcitriol

First Posted Date: 2014-02-12

Last Posted Date: 2021-08-02

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT02061384

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines

Conditions: Traumatic Brain Injury

First Posted Date: 2014-02-11

Last Posted Date: 2017-05-30

Lead Sponsor: University of Washington

Target Recruit Count: 780

Registration Number: NCT02059941

Locations: 🇧🇴
Hospital Viedma, Cochabamba, Bolivia
🇧🇴
Hospital Japones, Santa Cruz de la Sierra, Bolivia
🇨🇴
Fundacion Clinica Campbell, Barranquilla, Colombia

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy